MYCN contributes to the malignant characteristics of erythroleukemia through EZH2-mediated epigenetic repression of p21
Cited by 21
Related Papers
Novel Mechanism of Lapatinib Resistance in HER2-Positive Breast Tumor Cells: Activation of AXL
|Cancer Research|2009|490
GPR30-mediated HMGB1 upregulation in CAFs induces autophagy and tamoxifen resistance in ERα-positive breast cancer cells
|Aging|2021|57
TRIM22 confers poor prognosis and promotes epithelial-mesenchymal transition through regulation of AKT/GSK3β/β-catenin signaling in non-small cell lung cancer
|Oncotarget|2017|41
Nimotuzumab enhances radiation sensitivity of NSCLC H292 cells in vitro by blocking epidermal growth factor receptor nuclear translocation and inhibiting radiation-induced DNA damage repair
|OncoTargets and Therapy|2015|37
Regulation of the Muscarinic M3 Receptor by Myocardin-Related Transcription Factors
|Frontiers in Physiology|2021|13